Evidence map›Paper›PMID 33441624›Full record

ArticleScientific reports2021

Retinal capillary rarefaction is associated with arterial and kidney damage in hypertension.

Shaun Frost, Janis Marc Nolde, Justine Chan, Anu Joyson, Cynthia Gregory, Revathy Carnagarin, Lakshini Y Herat, Vance B Matthews, Liam Robinson, Janardhan Vignarajan and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06098300 (Effects of Change in Blood Pressure on Retinal Capillary Rarefaction in Patients With Arterial Hypertension - a Pilot Study), which is not on this map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06098300 recruitingnot on this mapstarted 2023, after this paper: background citation

Effects of Change in Blood Pressure on Retinal Capillary Rarefaction in Patients With Arterial Hypertension - a Pilot Study

TypeobservationalSponsorMedical University of ViennaRan2023 to 2025Enrolled30ConditionsArterial Hypertension, Blood Pressure, High
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Pathophysiology and Clinical Relevance of Microvascular Remodeling in Arterial Hypertension.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Observational
  18. Article
  19. METTL3-mediatedTheranostics · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Shaun FrostCommonwealth Scientific and Industrial Research Organisation (CSIRO) Health and Biosecurity, Brockway Rd Floreat 6014, Private Bag 5, Wembley, WA, 6913, Australia. shaun.frost@csiro.au.
Janis Marc NoldeDobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit/Medical Research Foundation, University of Western Australia, Perth, Australia.ORCID 0000-0001-6864-8514
Justine ChanDobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit/Medical Research Foundation, University of Western Australia, Perth, Australia.
Anu JoysonDobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit/Medical Research Foundation, University of Western Australia, Perth, Australia.
Cynthia GregoryDobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit/Medical Research Foundation, University of Western Australia, Perth, Australia.
Revathy CarnagarinDobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit/Medical Research Foundation, University of Western Australia, Perth, Australia.
Lakshini Y HeratDobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit/Medical Research Foundation, University of Western Australia, Perth, Australia.
Vance B MatthewsDobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit/Medical Research Foundation, University of Western Australia, Perth, Australia.
Liam RobinsonCommonwealth Scientific and Industrial Research Organisation (CSIRO) Health and Biosecurity, Brockway Rd Floreat 6014, Private Bag 5, Wembley, WA, 6913, Australia.
Janardhan VignarajanCommonwealth Scientific and Industrial Research Organisation (CSIRO) Health and Biosecurity, Brockway Rd Floreat 6014, Private Bag 5, Wembley, WA, 6913, Australia.
David PrenticePerron Institute for Neurological and Translational Science, Perth, Australia.
Yogesan KanagasingamSchool of Medicine, University of Notre Dame Australia, Fremantle, Australia.
Markus P SchlaichDobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit/Medical Research Foundation, University of Western Australia, Perth, Australia.
The University of Western Australia · AUAustralian e-Health Research Centre · AUBaker Heart and Diabetes Institute · AUCommonwealth Scientific and Industrial Research Organisation · AUPerron Institute for Neurological and Translational Science · AUThe University of Notre Dame Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microvascular disease and rarefaction are key pathological hallmarks of hypertension. The retina uniquely allows direct, non-invasive investigation of the microvasculature. Recently developed optical coherence tomography angiography now allows investigation of the fine retinal capillaries, which may provide a superior marker of overall vascular damage. This was a prospective cross-sectional study to collect retinal capillary density data on 300 normal eyes from 150 hypertensive adults, and to investigate possible associations with other organ damage markers. The average age of participants was 54 years and there was a greater proportion of males (85; 57%) than females. Multivariate, confounder adjusted linear regression showed that retinal capillary rarefaction in the parafovea was associated with increased pulse wave velocity (β = - 0.4, P = 0.04), log-albumin/creatinine ratio (β = - 0.71, P = 0.003), and with reduced estimated glomerular filtration rate (β = 0.04, P = 0.02). Comparable significant associations were also found for whole-image vascular-density, for foveal vascular-density significant associations were found with pulse wave velocity and estimated glomerular filtration rate only. Our results indicate that retinal capillary rarefaction is associated with arterial stiffness and impaired kidney function. Retinal capillary rarefaction may represent a useful and simple test to assess the integrated burden of hypertension on the microvasculature irrespective of current blood pressure levels.

Indexed as

ArteriesBlood PressureCapillariesCross-Sectional StudiesFemaleFluorescein AngiographyFovea CentralisGlomerular Filtration RateHumansHypertensionKidneyMaleMicrocirculationMicrovascular RarefactionMicrovesselsMiddle Aged

Identifiers

PMID33441624
PMCPMC7806760
OpenAlexW3119951481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.